
Thymosin Alpha 1 5mg
High-purity research peptide for laboratory use
$108.00
Out of stock
Benefits of Thymosin Alpha 1 Peptide
Immune System Enhancement: Boosts T-cell function and differentiation, strengthening immune response against infections, viruses, and diseases.
Antiviral Activity: Enhances antiviral immunity, showing efficacy against hepatitis B and C, HIV, and other viral infections.
Anti-Inflammatory Effects: Modulates inflammation by balancing cytokine production, aiding conditions like autoimmune diseases and chronic inflammation.
Cancer Support: Stimulates immune surveillance, potentially improving outcomes in cancers like lung and liver when used with other therapies.
Vaccine Adjuvant: Increases vaccine effectiveness by enhancing immune response to antigens, improving antibody production.
Antioxidant Properties: Reduces oxidative stress, protecting cells from damage and supporting overall health.
Chronic Disease Support: May improve symptoms in conditions like chronic fatigue syndrome, Lyme disease, and sepsis by boosting immunity.
Liver Protection: Supports liver function and repair, beneficial in cases of hepatitis or liver damage.
Trusted source for high-quality research peptides.
Support
info@peptidea.net
© 2025. All rights reserved.
Peptidea is a supplier of high-purity peptides, proteins, and amino acid derivatives intended solely for research and development purposes. Our products are not for human consumption. In research settings, peptides are often studied for their potential applications in areas such as weight management, anti-aging, and energy enhancement. All products are provided as lyophilized powders, requiring reconstitution with bacteriostatic water for research use. The statements on this website have not been evaluated by the US Food and Drug Administration, and our products are not intended to diagnose, treat, cure, or prevent any disease. Peptidea is a chemical supplier and is neither a compounding pharmacy nor a chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act, nor an outsourcing facility as defined under Section 503B of the same Act.